hydroxyl Radicals in E-Cigarette Vapor and E-Vapor Oxidative Potentials under Different Vaping Patterns.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Son (2019)
Investigating E-Cigarette Particle Emissions and human airway Depositions under Various E-Cigarette-Use Conditions.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Son (2020)
Thermodynamic behaviour of an e-cigarette: Investigation of nicotine delivery consistency using nicotine yield.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Soulet (2022)
Prediction of the transport, deposition, and absorption of multicomponent E-cigarette aerosols in a subject-specific mouth-to-G10 human respiratory system.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Sperry (2023)
assessment of cognitive and psychomotor impairment, subjective effects, and blood ThC concentrations following acute administration of oral and vaporized cannabis.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Spindle (2021)
Impact of e-liquid flavors on nicotine intake and pharmacology of e-cigarettes
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
St. helen (2017)
Comparison of Systemic Exposure to Toxic and/or Carcinogenic Volatile Organic Compounds (VOC) during Vaping, Smoking, and abstention.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
St.helen (2020)
an Examination of Differences in acute Nicotine Withdrawal Symptoms between Electronic Nicotine Delivery System and Combustible Cigarette Use.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Versella (2022)
On the toxicity of e-cigarettes consumption: Focus on pathological cellular mechanisms.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Vivarelli (2022)
What is the nicotine delivery profile of electronic cigarettes?
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Voos (2019)